Pain Control and Parent Mental Health Among Pediatric Inpatients

Andrew Barnes1, Ashley Tollefson2, Patricia Hickey3

  • 1Department of Pediatrics and drbarnes@umn.edu.

Hospital Pediatrics
|February 9, 2017
PubMed

Insights

Poor pain control in hospitalized children is linked to parental mental health. Higher parental anxiety and depression correlate with worse pain management for children, emphasizing the need for parental support.

Area of Science:

  • Pediatric healthcare research
  • Clinical psychology
  • Pain management

Background:

  • Inadequate pain management affects over half of hospitalized children, diminishing their quality of life.
  • Understanding the interplay between child pain and parental psychological factors is crucial for improving care.

Purpose of the Study:

  • To investigate the relationship between inpatient pain control and psychological factors in children and parents.
  • To test hypotheses linking pain control to child executive function, parent mindfulness, and parent mental health symptoms.

Main Methods:

  • Observational study involving 81 pediatric inpatients.
  • Data collected on nurse-recorded pain scores, child executive function, and parental mindfulness and mental health.
  • Linear mixed models used to analyze associations with pain scores over time.

Main Results:

  • Pain control was significantly associated with time and baseline pain levels.
  • Parental anxiety and depression were significantly related to poorer pain control in children.
  • Child age, gender, and parent education were adjusted for in the analysis.

Conclusions:

  • Worsening child pain control is associated with increased parental anxiety and depression.
  • Highlights the critical need for mental health resources for parents of hospitalized children experiencing pain.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
844
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343